Regulus Therapeutics Inc.
NASDAQ:RGLS
1.49 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 23.829 | 24.228 | 60.383 | 31.087 | 34.121 | 13.935 | 13.519 | 76.111 | 115.319 | 37.327 | 114.005 | 40.552 | 9.175 |
Short Term Investments
| 0 | 14.932 | 0 | 0 | 0 | 0 | 46.555 | 61.17 | 98.103 | 122.416 | 96.198 | 57.548 | 28.969 |
Cash and Short Term Investments
| 23.829 | 39.16 | 60.383 | 31.087 | 34.121 | 13.935 | 60.074 | 76.111 | 115.319 | 159.743 | 114.005 | 98.1 | 38.144 |
Net Receivables
| -0.003 | 3.069 | 3.069 | 0.503 | 1.141 | 0.026 | 0.373 | 1.657 | 10.021 | 0.274 | 0.079 | 0 | 0 |
Inventory
| 0.003 | 0.003 | 0.003 | 3.314 | 3.924 | 4.194 | 4.783 | 5.552 | -10.021 | 0 | -0.079 | 0 | 0 |
Other Current Assets
| 1.34 | 1.847 | 1.78 | 1.826 | 1.221 | 1.14 | 1.506 | 11.363 | 18.939 | 4.934 | 3.177 | 0.829 | 0.522 |
Total Current Assets
| 25.169 | 44.079 | 65.235 | 36.73 | 40.407 | 19.295 | 66.736 | 87.474 | 134.258 | 164.951 | 117.182 | 98.929 | 38.666 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 2.538 | 2.575 | 2.845 | 0.472 | 0.921 | 7.806 | 9.708 | 11.83 | 5.4 | 3.568 | 3.768 | 3.31 | 3.11 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.033 | 0.062 | 0.083 | 0.125 | 0.266 | 0.5 | 0.775 | 1.015 | 1.081 | 1.15 | 1.128 | 1.154 | 0.98 |
Goodwill and Intangible Assets
| 0.033 | 0.062 | 0.083 | 0.125 | 0.266 | 0.5 | 0.775 | 1.015 | 1.081 | 1.15 | 1.128 | 1.154 | 0.98 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 3.01 | 0 | 0.291 | 0.277 | 0.487 | 0.326 | 0.59 | 0.342 | 0.344 | 1.811 | 0.987 | 0.125 | 0.125 |
Total Non-Current Assets
| 5.581 | 2.637 | 3.219 | 0.874 | 1.674 | 8.632 | 11.073 | 13.187 | 6.825 | 6.529 | 5.883 | 4.589 | 4.215 |
Total Assets
| 30.75 | 46.716 | 68.454 | 37.604 | 42.081 | 27.927 | 77.809 | 100.661 | 141.083 | 171.48 | 123.065 | 103.518 | 42.881 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 0.204 | 0.175 | 0.285 | 0.535 | 1.321 | 1.714 | 5.743 | 5.84 | 2.717 | 2.188 | 1.172 | 0.311 | 0.501 |
Short Term Debt
| 2.047 | 4.511 | 0.589 | 4.652 | 14.631 | 16.575 | 19.859 | -0.072 | -1.194 | 23.397 | -4.888 | 0 | 0.377 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.206 |
Deferred Revenue
| 0 | 0 | -0.589 | 3.421 | 0.006 | 2.572 | 0.072 | 0.072 | 1.194 | 3.097 | 4.888 | 10.451 | 10.735 |
Other Current Liabilities
| 6.257 | 6.971 | 4.942 | 2.97 | 5.64 | 5.785 | 6.926 | 7.895 | 8.721 | -19.984 | 4.31 | 2.006 | 1.237 |
Total Current Liabilities
| 8.508 | 11.657 | 5.227 | 11.578 | 21.598 | 26.646 | 32.6 | 13.735 | 11.438 | 8.698 | 5.482 | 12.768 | 12.85 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 1.055 | 1.768 | 7.09 | 0 | 0 | 0 | 0 | 19.802 | 0 | 23.397 | 11.279 | 10.134 | 10.438 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0.006 | 1.921 | 2.065 | 3.259 | 6.349 | 11.388 | 17.756 | 16.987 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.438 |
Other Non-Current Liabilities
| 0 | 0 | 1.179 | 0 | 0.468 | 7.129 | 8.072 | 8.984 | 2.308 | 1.022 | 1.459 | 0.767 | 44.538 |
Total Non-Current Liabilities
| 1.055 | 1.768 | 8.269 | 0 | 0.468 | 7.135 | 9.993 | 30.851 | 5.567 | 30.768 | 24.126 | 28.657 | 71.525 |
Total Liabilities
| 9.563 | 13.425 | 13.496 | 11.578 | 22.066 | 33.781 | 42.593 | 44.586 | 17.005 | 39.466 | 29.608 | 41.425 | 84.375 |
Equity: | |||||||||||||
Preferred Stock
| 0.005 | 0.005 | 0.005 | 0.002 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.02 | 0.017 | 0.146 | 0.067 | 0.021 | 0.009 | 0.104 | 0.053 | 0.053 | 0.049 | 0.042 | 0.036 | 0 |
Retained Earnings
| -513.213 | -483.176 | -454.853 | -427.045 | -411.315 | -392.723 | -345.858 | -273.351 | -191.515 | -135.767 | -79.087 | -60.419 | -43.011 |
Accumulated Other Comprehensive Income/Loss
| -0.001 | -0.012 | 0 | 0 | 0 | -9.894 | -0.134 | -0.123 | -0.133 | -0.197 | -0.016 | -0.052 | -0.067 |
Other Total Stockholders Equity
| 534.376 | 516.457 | 509.66 | 453.002 | 431.305 | 396.754 | 381.104 | 329.496 | 315.673 | 267.929 | 172.518 | 122.528 | 1.584 |
Total Shareholders Equity
| 21.187 | 33.291 | 54.958 | 26.026 | 20.015 | -5.854 | 35.216 | 56.075 | 124.078 | 132.014 | 93.457 | 62.093 | -41.494 |
Total Equity
| 21.187 | 33.291 | 54.958 | 26.026 | 20.015 | -5.854 | 35.216 | 56.075 | 124.078 | 132.014 | 93.457 | 62.093 | -41.494 |
Total Liabilities & Shareholders Equity
| 30.75 | 46.716 | 68.454 | 37.604 | 42.081 | 27.927 | 77.809 | 100.661 | 141.083 | 171.48 | 123.065 | 103.518 | 42.881 |